Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2010 Jul;54(3):269-74.
doi: 10.1097/QAI.0b013e3181ce6b19.

The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda

Samuel Deok-jong Yoo  1 , William Worodria, J L Davis, Adithya Cattamanchi, Saskia den Boon, Rachel Kyeyune, Harriet Kisembo, Laurence Huang
Affiliations

The prevalence and clinical course of HIV-associated pulmonary cryptococcosis in Uganda

Samuel Deok-jong Yoo et al. J Acquir Immune Defic Syndr. 2010 Jul.

Abstract

Background: The prevalence and clinical course of pulmonary cryptococcosis in Sub-Saharan Africa are not well described.

Methods: Consecutive HIV-infected adults hospitalized at Mulago Hospital (Kampala, Uganda) between September 2007 and July 2008 with cough >or=2 weeks were enrolled. Patients with negative sputum smears for acid-fast bacilli were referred for bronchoscopy with bronchoalveolar lavage (BAL). BAL fluid was examined for mycobacteria, Pneumocystis jirovecii, and fungi. Patients were followed 2 and 6 months after hospital discharge.

Results: Of 407 patients enrolled, 132 (32%) underwent bronchoscopy. Of 132 BAL fungal cultures, 15 (11%) grew Cryptococcus neoformans. None of the patients were suspected to have pulmonary cryptococcosis on admission. The median CD4 count among those with pulmonary cryptococcosis was 23 cells per microliter (interquartile range = 7-51). Of 13 patients who completed 6-month follow-up, 4 died and 9 were improved, including 5 who had started antiretroviral therapy but had not received antifungal medication.

Conclusions: Pulmonary cryptococcosis is common in HIV-infected tuberculosis suspects in Uganda. Early initiation of antiretroviral therapy in those with isolated pulmonary infection may improve outcomes, even without antifungal therapy. This finding suggests that some HIV-infected patients with C. neoformans isolated from respiratory samples may have colonization or localized infection.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Numbers of patients screened, eligible, and enrolled
See this image and copyright information in PMC

References

    1. Kobayashi G. Fungi. In: Davis BD, editor. Microbiology. Philadelphia: J.B: Lippincott Company; 1980. p. 751.
    1. Park BJ, Wannemuehler KA, Marston BJ, et al. Estimation of the current global burden of cryptococcal meningitis among persons living with HIV/AIDS. AIDS. 2009;23(4):525–530. - PubMed
    1. Powderly WG, Finkelstein D, Feinberg J, et al. NIAID AIDS Clinical Trials Group. A randomized trial comparing fluconazole with clotrimazole troches for the prevention of fungal infections in patients with advanced human immunodeficiency virus infection. N Engl J Med. 1995;332(11):700–705. - PubMed
    1. French N, Gray K, Watera C, et al. Cryptococcal infection in a cohort of HIV-1-infected Ugandan adults. AIDS. 2002;16:1031–1038. - PubMed
    1. Churchyard GJ, Kleinschmidt I, Corbett EL, et al. Factors associated with an increased case-fatality rate in HIV-infected and non-infected South African gold miners with pulmonary tuberculosis. Int J Tuberc Lung Dis. 2000;4(8):705–712. - PubMed

Publication types

MeSH terms

Substances